Trial
NCT04189315
Relieving Burden of Hypophosphatasia in Adults With Functional Impairment Due to Chronic Disease
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Alexion Pharmaceuticals, Inc.
Collaborators
—
Condition
Hypophosphatasia
Intervention
asfotase alfa
Why stopped
R\&D portfolio review and in light of the global impact of the COVID-19 pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-06-04